Cat. No. | Product name | CAS No. |
DC60189 | CDDO-dhTFEA Featured | 1191265-33-4 |
DC60190 |
TAS4464
Featured
TAS4464 is a highly potent and selective inhibitor of NEDD8 (IC50 of 0.955 nM). TAS4464 selectively inhibited NAE relative to the other E1s UAE and SAE. TAS4464 treatment inhibited cullin neddylation and subsequently induced the accumulation of CRL substrates such as CDT1, p27, and phosphorylated IκBα in human cancer cell lines. TAS4464 showed greater inhibitory effects than those of the known NAE inhibitor MLN4924 both in enzyme assay and in cells. |
1848959-10-3 |
DC60191 | Tenofovir Alafenamide Impurity 1 Featured | 342631-41-8 |
DC60194 |
Derazantinib dihydrochloride
Featured
Derazantinib is a multi-kinase inhibitor with pan-FGFR activity which has shown preliminary therapeutic activity against FGFR2 fusion-positive intrahepatic cholangiocarcinoma (iCCA). Derazantinib dihydrochloride is a salt of Derazantinib. |
1821329-75-2 |
DC60195 |
Batefenterol Succinate
Featured
Batefenterol Succinate is a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties. |
945905-37-3 |
DC60196 |
K-Ras G12C-IN-4
Featured
K-Ras G12C-IN-4, compound 1, is a potent Covalent Inhibitor of KRAS. |
2376328-55-9 |
DC60197 | Pinacol Featured | 76-09-5 |
DC60198 |
GN44028
Featured
GN44028 inhibits HIF-1α. GN44028 surpresses HIF-1α transcriptional activity without affecting both HIF-1α protein accumulation and HIF-1α/HIF-1β heterodimerization in nuclei under the hypoxic conditions, suggesting that GN44028 probably affectes the transcriptional pathway induced by the HIF-1α/HIF-1β heterodimer. |
1421448-26-1 |
DC60199 |
Bifluranol
Featured
Bifluranol (brand name Prostarex; former developmental code name BX-341) is a synthetic nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that has been used as an antiandrogen in the United Kingdom in the treatment of benign prostatic hyperplasia. It exerts functional antiandrogen effects by binding to and activating the estrogen receptor in the pituitary gland, consequently suppressing the secretion of luteinizing hormone (and hence acting as an antigonadotropin) and thereby reducing gonadal androgen production and systemic androgen levels. |
34633-34-6 |
DC60200 |
SEP-363856 isomer
Featured
R isomer of SEP-363856. |
1310422-40-2 |
DC58060 |
VV116 (non-deuterated)
Featured
non-deuterated form of VV116.VV116 is an oral drug candidate of nucleoside analog against SARS-CoV-2. |
2647442-13-3 |
DC58062 |
4-Nitrophenylrhamnoside
Featured
4-Nitrophenyl α-L-rhamnopyranoside is a chromogenic substrate for naringinase. |
18918-31-5 |
DC58063 |
HG106
Featured
HG106 is a potent SLC7A11 inhibitor and enhances ROS generation, ER stress, and ultimately growth arrest specifically in KRAS-mutant lung adenocarcinoma (LUAD). |
928712-10-1 |
DC58110 |
Dclk1-IN-1
Featured
DCLK1-IN-1 is a selective, oral bioavailability in vivo-compatible chemical probe of the doublecortin like kinase 1 (DCLK1 kinase) domain. DCLK1-IN-1 inhibits DCLK1 and DCLK2 kinases (IC50: DCLK1=9.5/57.2 nM and DCLK2=31/103 nM in binding and kinase assay, respectively). DCLK1-IN-1 shows low toxicity, and can investigate DCLK1 biology and establish its role in cancer, like DCLK1+ pancreatic ductal adenocarcinoma (PDAC)[1]. |
2222635-15-4 |
DC47877 |
tri-GalNAc-COOH (acetylation)
Featured
tri-GalNAc-COOH acetylation is the acetylated and modified form of tri-GalNAc-COOH. tri-GalNAc-COOH acetylation can be used for the synthesis of LYTAC. |
|
DC47881 |
TMX-4116
Featured
TMX-4116 is a casein kinase 1α (CK1α) degrader. TMX-4116 shows the degradation preference for CK1α with DC50s less than 200 nM in MOLT4, Jurkat, and MM.1S cells. TMX-4116 can be used for the research of multiple myeloma. |
|
DC47884 |
TLR4-IN-C34-C2-COOH
Featured
TLR4-IN-C34-C2-COO is a linker that incorporates TLR4 inhibitor TLR4-IN-C34. TLR4-IN-C34 inhibits TLR4 in enterocytes and macrophages, and reduces systemic inflammation in mouse models of endotoxemia and necrotizing enterocolitis. |
1159408-54-4 |
DC47886 |
Thalidomide-Piperazine 5-fluoride
Featured
Thalidomide-Piperazine 5-fluoride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. |
2222114-22-7 |
DC47894 |
SR-0813
Featured
SR-0813 is a potent and selective ENL/AF9 YEATS domain inhibitor. SR-0813 has IC50 and EC50 values of 25 nM and 205 nM for ENL YEATS domain, respectively. SR-0813 has IC50 and EC50 values of 311 nM and 76 nM (CETSA) for AF9 YEATS domain, respectively. SR-0813 binds MAP3K19 with over 100-fold lower affinity (Kd=3.5 μM) than ENL YEATS (Kd=30 nM). SR-0813 can be used for the research of acute leukemia. |
2597186-19-9 |
DC47928 |
PCC0208017
Featured
PCC0208017 is a microtubule affinity regulating kinases (MARK3/MARK4) inhibitor with IC50s of 1.8 and 2.01 nM, respectively. PCC0208017 has much lower inhibitory activity against MARK1 and MARK2, with IC50s of 31.4 and 33.7 nM, respectively. PCC0208017 suppresses glioma progression in vitro and in vivo. PCC0208017 disrupts microtubule dynamics and induces G2/M phase cell cycle arrest and cell apoptosis. PCC0208017 demonstrates robust antitumor activity in vivo and displays good BBB permeability. |
2623158-64-3 |
DC47938 |
NCT-58
Featured
NCT58(NCT 58) is a potent inhibitor of C-terminal HSP90. NCT-58 does not induce the heat shock response (HSR) due to its targeting of the C-terminal region and elicits anti-tumor activity via the simultaneous downregulation of HER family members as well as inhibition of Akt phosphorylation. NCT-58 kills Trastuzumab-resistant breast cancer stem-like cells. NCT-58 induces apoptosis in HER2-positive breast cancer cells. |
2411429-33-7 |
DC47939 |
NBI-921352
Featured
NBI921352 is a Nav1.6 inhibitor with an IC50 value of 3.765 μM. |
2154408-63-4 |